"Cost Sharing" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Provisions of an insurance policy that require the insured to pay some portion of covered expenses. Several forms of sharing are in use, e.g., deductibles, coinsurance, and copayments. Cost sharing does not refer to or include amounts paid in premiums for the coverage. (From Dictionary of Health Services Management, 2d ed)
| Descriptor ID |
D017047
|
| MeSH Number(s) |
N03.219.151.170 N03.219.521.576.090
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cost Sharing".
Below are MeSH descriptors whose meaning is more specific than "Cost Sharing".
This graph shows the total number of publications written about "Cost Sharing" by people in this website by year, and whether "Cost Sharing" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cost Sharing" by people in Profiles.
-
Accuracy of Physician Estimates of Out-of-Pocket Costs for Medication Filling. JAMA Netw Open. 2021 11 01; 4(11):e2133188.
-
Patient cost sharing during poly(adenosine diphosphate-ribose) polymerase inhibitor treatment in ovarian cancer. Am J Obstet Gynecol. 2021 07; 225(1):68.e1-68.e11.
-
Financial Burden for Patients With Chronic Myeloid Leukemia Enrolled in Medicare Part D Taking Targeted Oral Anticancer Medications. J Oncol Pract. 2017 02; 13(2):e152-e162.
-
The Impact of Tobacco Smoke Exposure on Childhood Asthma in a Medicaid Managed Care Plan. Chest. 2016 Mar; 149(3):721-8.
-
Overcoming barriers to discussing out-of-pocket costs with patients. JAMA Intern Med. 2014 Jun; 174(6):849-50.
-
Continental Divide? The attitudes of US and Canadian oncologists on the costs, cost-effectiveness, and health policies associated with new cancer drugs. J Clin Oncol. 2010 Sep 20; 28(27):4149-53.